Literature DB >> 7835592

Immunostaining for membrane attack complex of complement is related to cell necrosis in fulminant and acute hepatitis.

B N Pham1, J F Mosnier, F Durand, J Y Scoazec, O Chazouilleres, F Degos, J Belghiti, C Degott, J P Benhamou, S Erlinger.   

Abstract

BACKGROUND/AIMS: Complement activation is one of the mechanisms involved in inflammatory lesions. Initiation of the complement terminal pathway at a cell surface leads to the formation of a cytolytic membrane attack complex. Our study assess whether a membrane attack complex-associated mechanism is involved in liver cell necrosis of fulminant and subfulminant hepatitis.
METHODS: Immunostaining for membrane attack complex was compared with immunostaining for cytokeratin and complement inhibitory proteins such as membrane cofactor protein, decay-accelerating factor, and homologous restriction factor in 15 patients with fulminant hepatitis and 5 patients with nonfulminant acute hepatitis.
RESULTS: In all patients, hepatocytes surrounding necrotic areas, but not those at a distance, were stained for membrane attack complex, whereas the opposite staining pattern for membrane cofactor protein was observed. In controls, no hepatocyte staining for membrane attack complex was observed, whereas membrane cofactor protein, but not decay-accelerating factor or homologous restriction factor, was detected on hepatocytes.
CONCLUSIONS: Complement activation by antibody-dependent or non-antibody-dependent mechanisms might be involved in the pathogenesis of either fulminant or acute hepatitis. Modulation of membrane cofactor protein expression on hepatocytes might contribute to the sensitivity of hepatocytes to membrane attack complex and subsequent cell lysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7835592     DOI: 10.1016/0016-5085(95)90079-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.

Authors:  O B Spiller; O Criado-García; S Rodríguez De Córdoba; B P Morgan
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Quantification of C4d deposition and hepatitis C virus RNA in tissue in cases of graft rejection and hepatitis C recurrence after liver transplantation.

Authors:  Alice Tung Wan Song; Evandro Sobroza de Mello; Venâncio Avancini Ferreira Alves; Norma de Paula Cavalheiro; Carlos Eduardo Melo; Patricia Rodrigues Bonazzi; Fatima Mitiko Tengan; Maristela Pinheiro Freire; Antonio Alci Barone; Luiz Augusto Carneiro D'Albuquerque; Edson Abdala
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-02-13       Impact factor: 2.743

3.  Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.

Authors:  J H Sohn; H J Kaplan; H J Suk; P S Bora; N S Bora
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

4.  A Dual Role of Complement Activation in the Development of Fulminant Hepatic Failure Induced by Murine-Beta-Coronavirus Infection.

Authors:  Yingying Fang; Yan Guo; Tongtong Gao; Xuelian Han; Yuting Jiang; Min Li; Wei Xue; Binhui Yang; Yujun Cui; Shihui Sun; Guangyu Zhao
Journal:  Front Cell Infect Microbiol       Date:  2022-04-29       Impact factor: 6.073

5.  Circulating complement factor H levels are associated with disease severity and relapse in autoimmune hepatitis.

Authors:  Manabu Hayashi; Kazumichi Abe; Masashi Fujita; Atsushi Takahashi; Hideharu Sekine; Hiromasa Ohira
Journal:  JHEP Rep       Date:  2022-04-29

6.  Complement and the alternative pathway play an important role in LPS/D-GalN-induced fulminant hepatic failure.

Authors:  Shihui Sun; Yan Guo; Guangyu Zhao; Xiaojun Zhou; Junfeng Li; Jingya Hu; Hong Yu; Yu Chen; Hongbin Song; Fei Qiao; Guilian Xu; Fei Yang; Yuzhang Wu; Stephen Tomlinson; Zhongping Duan; Yusen Zhou
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

7.  Complement alternative pathway activation in human nonalcoholic steatohepatitis.

Authors:  Filip M Segers; Froukje J Verdam; Charlotte de Jonge; Bas Boonen; Ann Driessen; Ronit Shiri-Sverdlov; Nicole D Bouvy; Jan Willem M Greve; Wim A Buurman; Sander S Rensen
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

8.  Complement System as a Target for Therapies to Control Liver Regeneration/Damage in Acute Liver Failure Induced by Viral Hepatitis.

Authors:  Juliana Gil Melgaço; Carlos Eduardo Veloso; Lúcio Filgueiras Pacheco-Moreira; Claudia Lamarca Vitral; Marcelo Alves Pinto
Journal:  J Immunol Res       Date:  2018-10-08       Impact factor: 4.818

9.  3'mRNA sequencing reveals pro-regenerative properties of c5ar1 during resolution of murine acetaminophen-induced liver injury.

Authors:  Sina Gonther; Malte Bachmann; Itamar Goren; Arnaud Huard; Andreas Weigert; Jörg Köhl; Heiko Mühl
Journal:  NPJ Regen Med       Date:  2022-01-27

10.  Complement Factor 3 Could Be an Independent Risk Factor for Mortality in Patients with HBV Related Acute-on-Chronic Liver Failure.

Authors:  Geng-Lin Zhang; Ting Zhang; Yi-Nong Ye; Jing Liu; Xiao-Hong Zhang; Chan Xie; Liang Peng; Zhi-Liang Gao
Journal:  Biomed Res Int       Date:  2016-04-06       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.